Both SART3 and CPLX4 are jointly inhibited by AKAP4, DSG4, and CIB4. SART3 is a gene encoding an RNA-binding nuclear protein that is a tumor-rejection antigen containing tumor epitopes [25]. Here, SART3 is linked to neoplasm.